Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 34OTHER 21NIH 2NETWORK 2OTHER_GOV 1INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Proflavine 9pembrolizumab 2Tacrolimus 2Pyridostigmine Bromide 2Prednisone 2Microbial Collagenase 2sargramostim 1plerixafor 1pegfilgrastim 1olaparib 1nilotinib 1macimorelin 1keyhole-limpet hemocyanin 1ethyl pyruvate 1compound W 1blinatumomab 1Watchful Waiting 1Uracil 1Tegafur 1Surgical Procedures, Operative 1Steroids 1Sodium Chloride 1Sirolimus 1Salicylates 1Peptides 1PM 01183 1Mycophenolic Acid 1Monatide (IMS 3015) 1Mifepristone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × PM 01183 × Clear all
NCT02684318 2017-06-22

Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

Poveda, Andrés, M.D.

Phase 1/2 Unknown
100 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡